Displaying items 61-72 of 1604
» View wsbtradio.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-134
•
Next >
-
Study questions fish oil benefit before heart attack
ReutersNEW YORK (Reuters Health) - Fish oil supplements did not prevent heart problems in people who hadn't had a heart attack yet, in a large long-term study from Italy. The study - a gold-standard randomized, controlled trial - tested the effect of omega-3...Tags: Medical Research, Dietary Supplements, American Heart Association, Placebo, Heart Problems
-
Stem cells may aid in sports injuries
Until recently, I didn't know that I could use stem cells to help heal my bum shoulder. Perhaps that's because I don't use said shoulder for hurling baseballs or footballs at speeds approaching the sound barrier for obscene amounts of money. I can see...Tags: Coral Springs, Medical Research, Placebo, Boca Raton, Physical Fitness and Exercise
-
10 Things to Know for Today
Your daily look at late-breaking news, upcoming events and the stories that will be talked about today: 1. DEATH TOLL EXPECTED TO SOAR IN BANGLADESH One estimate said as many as 1,400 may be found dead in the collapsed building as emergency workers...Tags: National Basketball Association, FBI, Kermit Gosnell, Entertainment, AEG
-
BRIEF-FDA staff ask if another study needed for Aveo cancer drug
ReutersApril 30 (Reuters) - *FDA staff reviewers to ask expert panel whether single trial for Aveo's kidney cancer drug Tivozanib is sufficient to support approval *FDA staff reviewers to ask panel whether another trial needed for Aveo's Tivozanib, "given the...Tags: Renal cell carcinoma, Trials
-
FDA staff to ask expert panel if new trial needed for Aveo drug
ReutersBy Toni Clarke April 30 (Reuters) - Staff reviewers for the U.S. Food and Drug Administration will ask a panel of outside medical experts if another clinical trial is needed before an experimental kidney cancer drug made by Aveo Pharmaceuticals Inc and...Tags: Renal cell carcinoma, Drugs and Medicines, Trials, Bayer AG
-
FDA staff says Allergan's new dermal filler effective
ReutersApril 30 (Reuters) - Reviewers for the U.S. Food and Drug Administration said Allergan Inc's dermal filler, Juvéderm Voluma XC, was effective in correcting volume deficit in the middle of the face at six months of treatment. The reviewers said that if...Tags: NYSE Euronext, Inc., Stock Market, Facial Wrinkles, Allergan Inc., Wells Fargo & Co.
-
Got diet milk?
In the face of troubling childhood obesity rates and what it sees as low milk consumption rates, the dairy industry says it has a solution: Offer kids flavored milk that uses low-calorie artificial sweeteners. The only problem, industry...
Tags: Beverage Industry, U.S. Department of Agriculture, Health and Safety at School, Consumer Goods Industries, Pediatrics
-
Wrigley halts production of caffeine gum following FDA concern
ReutersMay 8 (Reuters) - Wrigley temporarily halted production of its new Alert Energy Caffeine Gum in response to concerns expressed by the U.S. Food and Drug Administration over the impact of caffeine on children and adolescents. The company said it had...Tags: Dietary Supplements, New Products, Vitamin Therapy, Herbal Supplements, Consumers
-
FDA warns pregnant migraine sufferers against anti-seizure drugs
The Food and Drug Administration is warning physicians that women who suffer migraine headaches and are pregnant or may become pregnant should not use the drugs valproate or valproic acid to prevent the severe headaches, in light of new evidence showing...
Tags: Depakote (drug), Bipolar Disorder, Migraine, Physical Conditions, Chemical Industry
-
BRIEF-Pfizer says has understanding from FDA on needed steps for Remoxy pain drug
ReutersApril 30 (Reuters) - Pfizer Inc : * Says has had discussions with FDA on possible resubmssion of marketing application for remoxy pain drug * CEO says has "clear understanding" from FDA of what is required before resubmitting application for drug,... -
REUTERS SUMMIT-Faster drug approvals a tonic for pharma industry
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Ben Hirschler NEW YORK, May 8 (Reuters) - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have...Tags: Bristol Myers Squibb Company, Medical Research, Pfizer Inc., Patents, Copyrights and Trademarks, Moody's Corporation
-
Pain Therapeutics, Durect shares soar on Pfizer's Remoxy comments
ReutersApril 30 (Reuters) - Shares of Pain Therapeutics Inc and Durect Corp rose more than 40 percent after partner Pfizer Inc said it is in talks with U.S. health regulators to find a way forward on the companies' painkiller, Remoxy. The U.S. Food and Drug...Tags: Pain Therapeutics, Durect Corporation, Pain
May 8, 2013
|Story| Reuters
May 1, 2013
|Story| Chicago Tribune
Apr 30, 2013
|Story| Aberdeen News
Apr 30, 2013
|Story| Reuters
Apr 30, 2013
|Story| Reuters
Apr 30, 2013
|Story| Reuters
May 9, 2013
|Story| Chicago Tribune
May 8, 2013
|Story| Reuters
May 6, 2013
|Story| Los Angeles Times
Apr 30, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
Apr 30, 2013
|Story| Reuters
Original site for Food and Drug Administration topic gallery.